Annual EBITDA
Summary
- Current Value
- As of today, CI annual EBITDA is $2.78B, down -65.50% on
- Historical Performance
- CI annual EBITDA is down -75.52% over the past 3 years, down -79.70% over the past 5 years
- All-Time High Comparison
- CI annual EBITDA is currently -79.70% below its historical high of $13.67B set on
- 3-Year Low Comparison
- CI annual EBITDA is at its 3-year low
- Sector Comparison
- CI annual EBITDA is higher than 96.24% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.78B | -65.5% | -75.5% | -79.7% | +28.4% | |
| Quarterly EBITDA | - | – | – | – | – | |
| TTM EBITDA | - | – | – | – | – | |
| Price | $281.44 | -9.2% | -1.9% | +22.0% | +542.3% | |
| PE Ratio | 12.68 | -49.9% | -5.0% | +26.8% | +41.5% | |
| Annual Revenue | $57.98B | -76.3% | -67.8% | -63.9% | +173.6% | |
| Annual EPS | $22.18 | +82.9% | +3.6% | -3.4% | +354.0% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | $5.96B | +57.7% | -12.2% | -29.8% | +341.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.33B | N/A | -75.5% |
| 5Y | $13.67B | N/A | -79.7% |
| All | $13.67B | -79.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.78B | at low | |
| 5Y | $2.78B | at low | |
| All | -$42.50M | +6629.4% |
EBITDA History
FAQ
What is the current annual EBITDA of CI?
As of today, CI annual EBITDA is $2.78B
What is 1-year change in CI annual EBITDA?
CI annual EBITDA is down -65.50% year-over-year
What is 3-year change in CI annual EBITDA?
CI annual EBITDA is down -75.52% over the past 3 years
How far is CI annual EBITDA from its all-time high?
CI annual EBITDA is currently -79.70% below its historical high of $13.67B set on December 31, 2020
How does CI annual EBITDA rank versus sector peers?
CI annual EBITDA is higher than 96.24% of companies in Healthcare sector
When is CI next annual earnings release?
As of today, the next annual earnings release for CI has not been scheduled
Quarterly EBITDA
Summary
- Status
- CI quarterly EBITDA is unknown
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | - | – | – | – | – | |
| Annual EBITDA | $2.78B | – | -65.5% | -75.5% | -79.7% | |
| TTM EBITDA | - | – | – | – | – | |
| Price | $281.44 | +6.0% | -9.2% | -1.9% | +22.0% | |
| PE Ratio | 12.68 | +8.3% | -49.9% | -5.0% | +26.8% | |
| Quarterly Revenue | $14.16B | -79.7% | -78.5% | -69.1% | -66.2% | |
| Quarterly EPS | $4.64 | -33.5% | -9.4% | +18.9% | -59.3% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Quarterly Net Income | $1.23B | -37.5% | -19.7% | +1.0% | -70.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.99B | N/A | |
| 3Y | $2.99B | N/A | |
| 5Y | $6.09B | N/A | N/A |
| All | $6.09B | N/A |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.32B | N/A | |
| 3Y | $820.00M | N/A | |
| 5Y | $820.00M | N/A | |
| All | -$1.23B | N/A |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CI?
CI quarterly EBITDA is unknown
What is CI quarterly EBITDA most recent change?
CI quarterly EBITDA change on December 31, 2025 is unknown
What is 1-year change in CI quarterly EBITDA?
CI quarterly EBITDA 1-year change is unknown
How far is CI quarterly EBITDA from its all-time high?
CI quarterly EBITDA vs all-time high is unknown
When is CI next earnings release?
The next earnings release for CI is on
TTM EBITDA
Summary
- Status
- CI TTM EBITDA is unknown
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | - | – | – | – | – | |
| Annual EBITDA | $2.78B | – | -65.5% | -75.5% | -79.7% | |
| Quarterly EBITDA | - | – | – | – | – | |
| Price | $281.44 | +6.0% | -9.2% | -1.9% | +22.0% | |
| PE Ratio | 12.68 | +8.3% | -49.9% | -5.0% | +26.8% | |
| TTM Revenue | $216.66B | -19.2% | -11.3% | +20.4% | +35.0% | |
| TTM EPS | $22.19 | -2.1% | +81.3% | +3.3% | -3.8% | |
| $5.96B | -25.2% | +13.2% | -29.0% | -45.1% | ||
| TTM Net Income | $6.25B | -4.6% | +65.4% | -7.9% | -26.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.67B | N/A | |
| 3Y | $11.40B | N/A | |
| 5Y | $13.81B | N/A | |
| All | $13.81B | N/A |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.04B | N/A | N/A |
| 3Y | $6.34B | N/A | |
| 5Y | $6.34B | N/A | |
| All | -$785.00M | N/A |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CI?
CI TTM EBITDA is unknown
What is CI TTM EBITDA most recent change?
CI TTM EBITDA change on December 31, 2025 is unknown
What is 1-year change in CI TTM EBITDA?
CI TTM EBITDA 1-year change is unknown
How far is CI TTM EBITDA from its all-time high?
CI TTM EBITDA vs all-time high is unknown
When is CI next earnings release?
The next earnings release for CI is on
EBITDA Formula
Data Sources & References
- CI Official Website www.cigna.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1739940/000173994026000006/0001739940-26-000006-index.htm
- CI Profile on Yahoo Finance finance.yahoo.com/quote/CI
- CI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ci
